Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net revenue $ 57,648 $ 71,229 $ 179,695 $ 221,647
Operating expenses:        
Cost of revenue [1] 13,629 17,832 43,971 54,851
Selling and marketing 14,186 15,116 40,463 50,756
Research and development 14,814 16,654 42,702 51,418
General and administrative 12,056 11,581 35,262 35,005
Depreciation and amortization 9,576 11,593 28,743 34,813
Restructuring and related 1,253 3,231 2,648 5,248
Total operating costs and expenses 65,514 76,007 193,789 232,091
Loss from operations (7,866) (4,778) (14,094) (10,444)
Other income (expense), net:        
Change in fair value of warrant liabilities (73) 276 37 929
Interest income, net 917 1,127 2,769 3,921
Other loss, net (1,802) (256) (2,807) (626)
Total other (loss) income, net (958) 1,147 (1) 4,224
Loss before income taxes (8,824) (3,631) (14,095) (6,220)
Income tax (expense) benefit (294) 534 (851) (55)
Net loss $ (9,118) $ (3,097) $ (14,946) $ (6,275)
Net loss per share attributable to Class A and Class B common stockholders:        
Basic (USD per share) $ (0.07) $ (0.02) $ (0.12) $ (0.05)
Diluted (USD per share) $ (0.07) $ (0.02) $ (0.12) $ (0.05)
Weighted average shares of common stock outstanding:        
Basic (shares) 125,695 125,007 125,467 130,997
Diluted (shares) 125,695 125,007 125,467 130,997
[1] Amounts exclude depreciation and amortization.